Practice guidance for social connection
Institute forSocial ConnectionFrameworks & toolkits

Practice note

How to Write a Funding Case a Commissioner Can Actually Use

A sequenced procedure for translating a social connection programme into the outcome language commissioners are already accountable for, with the evidence that supports each claim and what to leave out.

Measurement & EvaluationFunding & Commissioning

Photograph · Pexels

A commissioner reading your funding case is not asking whether loneliness is real. They are asking whether your programme reduces a cost line they are already accountable for — GP contacts, A&E attendances, staff turnover, care package escalation — and whether you can show that credibly enough to survive a panel. Most social connection funding bids fail not because the intervention is weak but because they are written in the wrong language: outcomes the applicant cares about, not outcomes the commissioner is scored on.

This is a procedure for closing that gap.

Step 1: Find out what the commissioner is actually accountable for

Before you write a word of the case, get the commissioning framework or service specification they are working against. Health and care commissioners are typically held to reductions in unplanned admissions, GP appointment volume, length of stay, or falls. Local authority commissioners answer to adult social care outcomes frameworks and safeguarding thresholds. Employers answer to absence rates, turnover, and presenteeism. Funders answer to whatever their own board has told them to report upward.

Your programme’s outcome — “reduced loneliness” — is rarely on that list. It has to be translated into something that is.

What this means in practice: don’t lead a funding case with “we reduce loneliness.” Lead with the line item the commissioner’s own dashboard tracks, then show the connection evidence as the mechanism, not the headline.

Step 2: Match your claims to the corresponding cost line

The table below pairs common commissioner cost lines with the connection evidence that actually supports a claim there — and flags where the evidence does not yet stretch that far.

Commissioner cost line What the evidence supports What it does not support
Mortality / long-term condition risk Holt-Lunstad’s 2010 meta-analysis found stronger social relationships associated with a 50% greater likelihood of survival; the American Heart Association’s 2022 scientific statement links isolation and loneliness to roughly 30% higher risk of heart attack, stroke, or death from either Neither shows that your specific programme changes mortality — these are population-level associations, not intervention trials
Older adults’ care escalation The National Academies’ 2020 consensus report calls for routine isolation assessment in health care and links isolation to worse health outcomes among older adults It does not quantify how much a given social prescribing referral reduces admissions
Sickness absence, staff turnover Cigna’s 2020 workplace data found lonely workers miss work roughly twice as often for illness and five times as often for stress This is a workplace-loneliness association, not evidence that a specific workplace programme reduces absence
Service use reduction from social prescribing A 2021 systematic review of social prescribing and loneliness found three of nine included studies reported reduced GP, emergency, social worker, or inpatient use Small sample of studies, heterogeneous designs — cite as a signal, not a guarantee
Loneliness reduction itself Two randomised trials now exist: the HEAL-HOA volunteering trial and a 2025 aged-care befriending RCT that cut UCLA Loneliness Scale scores by 2.4–2.7 points A follow-up HEAL-HOA trial found telephone-delivered behavioural activation outperformed befriending head-to-head, so “any social contact reduces loneliness” is no longer a safe claim to make unqualified

Use this table as a checking tool, not a script. If your programme is a weekly walking group for isolated older adults, cite the National Academies report and the mortality associations to explain why the commissioner should care, and cite the social prescribing service-use review to suggest what might follow — carefully, as a plausible pathway, not a promised outcome.

Step 3: Write the outcome chain, not the outcome

Commissioners are trained to be suspicious of a straight line from “we ran sessions” to “costs fell.” Give them the chain instead: attendance → increased social contact → (for some participants) reduced loneliness → (for some of those) reduced reliance on other services. Naming each link, and being honest about where the evidence thins out as you move along it, reads as more credible than claiming the whole chain in one sentence — because it is more credible.

The qualitative literature on social prescribing gives you good language for the middle links. A 2022 meta-synthesis found participants describe benefit that extends beyond contact itself to restored meaningful participation and purpose, and that structured, purposeful group activity appears to work better than unstructured contact. That distinction is worth stating explicitly in a bid: it tells the commissioner you are not proposing a drop-in social club and calling it an intervention.

Step 4: Name the evidence gap before the panel does

A 2025 systematic review protocol on social prescribing for older adults notes plainly that its effectiveness remains unclear despite growing adoption, and that only one peer-reviewed randomised controlled trial exists in the area. That is an uncomfortable sentence to put in your own funding bid. Put it in anyway, in your own words, then explain what you are doing to generate better evidence — a control comparison, a validated loneliness measure at baseline and follow-up, service-use data linkage. A commissioner who has seen a hundred social prescribing bids overselling weak evidence will trust the one that says “the trial base is thin, here’s how we’re contributing to it” over the one that claims certainty it doesn’t have.

The week-four write-off

Here is a specific failure mode worth naming in your own planning, even if you don’t put it in the bid. Commissioners often fund a pilot for six or twelve months, expect a report at the end, and quietly discount anything that looks like it was written to justify the money already spent. If your only outcome data point is measured at week four of a twelve-week programme — because that’s when the interim report was due — you will produce a number that looks like early enthusiasm, not durable change, and an experienced commissioner will read it that way. Baseline and endpoint measurement, at minimum, is not optional; anything less invites exactly the scepticism you’re trying to avoid.

Step 5: State the actual ask in the commissioner’s units

Close the case with a specific request stated in cost or capacity terms, not programme terms. Not “fund 200 group sessions” but “a marginal cost of £X per participant against a service line currently costing £Y, with the mechanism above and the following measurement plan attached.” The Surgeon General’s 2023 advisory frames social connection as belonging in the same category as other modifiable determinants of health, which is a useful sentence to borrow for framing — but it will not by itself persuade a commissioner scoring against a specific outcomes framework. Only your own cost-line translation will.

What this means in practice: every claim in the bid should answer “so what does this change on your dashboard,” not “so what does this change for the participant.” Both matter. Only one gets funded.

What this does not solve

This procedure helps you write a case that survives scrutiny. It does not manufacture evidence that doesn’t exist — the intervention literature for loneliness is still dominated by small trials, and social prescribing’s effect on service use rests on a handful of heterogeneous studies. Nor does it solve the reach problem: a commissioner-literate funding case still describes a programme that people had to seek out, refer into, or be referred to, and says nothing about the isolated adults who never reach a link worker’s caseload in the first place. Getting funded and reaching the people most affected are two different problems, and this article only addresses the first.

Sources

  1. Social Relationships and Mortality Risk: A Meta-analytic ReviewPLoS Medicine, July 2010
  2. Loneliness and Social Isolation as Risk Factors for Mortality: A Meta-Analytic ReviewPerspectives on Psychological Science, March 2015
  3. Effects of Objective and Perceived Social Isolation on Cardiovascular and Brain Health: A Scientific Statement From the American Heart AssociationJournal of the American Heart Association, August 2022
  4. Social Isolation and Loneliness in Older Adults: Opportunities for the Health Care SystemNational Academies of Sciences, Engineering, and Medicine, February 2020
  5. Loneliness and the Workplace: 2020 U.S. ReportCigna, January 2020
  6. Can Social Prescribing Foster Individual and Community Well-Being? A Systematic Review of the EvidenceInternational Journal of Environmental Research and Public Health, May 2021
  7. Understanding Loneliness: A Systematic Review of the Impact of Social Prescribing Initiatives on LonelinessPerspectives in Public Health, June 2021
  8. Do People Perceive Benefits in the Use of Social Prescribing to Address Loneliness and/or Social Isolation? A Qualitative Meta-SynthesisBMC Health Services Research, October 2022
  9. The Role of Social Prescribing in Alleviating Social Isolation and Loneliness in Older Adults: A Systematic Review ProtocolmedRxiv, July 2025
  10. The Effects of Volunteering on Loneliness Among Lonely Older Adults: The HEAL-HOA Dual Randomised Controlled TrialThe Lancet Healthy Longevity, November 2024
  11. Randomized Controlled Trial on the Impact of Befriending on Depression, Anxiety, Loneliness, and Social Support in Older People in Aged CareClinical Gerontologist, December 2025
  12. Behavioral Activation and Mindfulness Interventions in Reducing Loneliness and Improving Well-Being in Older Adults: The HEAL-HOA Randomized Clinical TrialPMC, March 2026
  13. Our Epidemic of Loneliness and Isolation: The U.S. Surgeon General Advisory on the Healing Effects of Social Connection and CommunityU.S. Office of the Surgeon General, May 2023